or Try an Advanced Search...

    Technical Analysis for AZTR - Azitra Inc.

    Grade Last Price % Change Price Change
    F 0.56 -3.96% -0.02
    AZTR closed down 3.96 percent on Friday, September 6, 2024, on 8 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AZTR trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction -3.96%
    Wide Bands Range Expansion -3.96%
    Oversold Stochastic Weakness -3.96%
    1,2,3 Pullback Bullish Bullish Swing Setup -5.56%
    Narrow Range Bar Range Contraction -5.56%
    Older End-of-Day Signals for AZTR ...

       Recent Intraday Alerts

    Alert Time
    Down 5% 2 days ago
    Fell Below Lower Bollinger Band 2 days ago
    Lower Bollinger Band Support 2 days ago
    Down 3% 2 days ago
    Fell Below Previous Day's Low 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AZTR Chart by TradingView
    Basic chart:

    Profile

    Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Molecular Biology Rare Diseases Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Pre Clinical Biopharmaceutical Biotherapeutic Products Ichthyosis

    Is AZTR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 28 Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
    Aug 23 AZTR: First ATR-12 Patient Screened
    Aug 22 Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
    Aug 21 Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    Aug 20 Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
    Jul 30 AZTR: Get Some Skin in the Game
    Jul 25 CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering
    Jul 24 Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings
    Jul 24 Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Jul 24 Azitra slides 28%, prices $10M shares and warrants
    See more AZTR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 68.4
    52 Week Low 0.492
    Average Volume 3,559,369
    200-Day Moving Average 13.83
    50-Day Moving Average 1.41
    20-Day Moving Average 0.66
    10-Day Moving Average 0.65
    Average True Range 0.22
    RSI (14) 38.65
    ADX 32.92
    +DI 43.39
    -DI 25.61
    Chandelier Exit (Long, 3 ATRs) 0.32
    Chandelier Exit (Short, 3 ATRs) 1.15
    Upper Bollinger Bands 0.76
    Lower Bollinger Band 0.57
    Percent B (%b) -0.03
    BandWidth 29.01
    MACD Line -0.23
    MACD Signal Line -0.30
    MACD Histogram 0.0679
    Fundamentals Value
    Market Cap 6.77 Million
    Num Shares 12.1 Million
    EPS -1.23
    Price-to-Earnings (P/E) Ratio -0.46
    Price-to-Sales 22.01
    Price-to-Book 2.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.64
    Resistance 3 (R3) 0.64 0.61 0.63
    Resistance 2 (R2) 0.61 0.59 0.61 0.62
    Resistance 1 (R1) 0.59 0.58 0.57 0.59 0.62
    Pivot Point 0.56 0.56 0.55 0.56 0.56
    Support 1 (S1) 0.53 0.54 0.52 0.53 0.50
    Support 2 (S2) 0.50 0.53 0.51 0.50
    Support 3 (S3) 0.48 0.50 0.49
    Support 4 (S4) 0.48